Ownership of patents is not the issue. Assignment could be but most, if not all inventors in large companies, assign their patents to the company. In this case the company has the right to do whatever they want with the patent rights but the inventor is still the patent holder.
Whoever has the patent rights has the option of licensing someone else to utilize the patent. My understanding is that BORK is licensed to use Kryron patents. I don't know what that license says but given that BORK is actively marketing Kryron applications I assume that BORK has a license, at lease for body armor, to develop a product and take it to market. BORK is doing a good job of that.
Compare BORK to other startups. We have a viable product, it has been demonstrated to exceed the competition, it can be reproduced, and exceeds projected customer expectations. Funding is not an issue.
Speculation is investing in something not fully known. If you knew everything it would not be speculation. BORK has demonstrated their capability several times without doubt. So, in evaluating the stock for investment, it is way ahead of almost all other startup companies in real value. Of course, you have to make your own decision about the speculative value versus the risk you are willing to take. IMO this is as close to a sure thing as God gives me. I will take this blessing and thank him from the bottom of my heart.
The assets are clear to me. John Bourque is a person of integrity, Kryron performs as advertised and way above the competition, and smart people are taking this to market. BORK has the marketing license and they are doing a spectacular job.
News 
Market Data 
Discover 
